Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$49.27 - $66.08 $879,469 - $1.18 Million
-17,850 Reduced 75.79%
5,703 $372,000
Q1 2022

May 16, 2022

BUY
$43.77 - $63.22 $1.03 Million - $1.49 Million
23,553 New
23,553 $1.49 Million
Q3 2020

Nov 16, 2020

SELL
$75.65 - $93.58 $522,665 - $646,544
-6,909 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$84.96 - $118.91 $586,988 - $821,549
6,909 New
6,909 $619,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.39B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Pdt Partners, LLC Portfolio

Follow Pdt Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.